Sethuraman Natarajan 4
4 · Entrada Therapeutics, Inc. · Filed Oct 18, 2024
Insider Transaction Report
Form 4
Sethuraman Natarajan
President, Research & Develop.
Transactions
- Sale
Common Stock
2024-10-16$18.00/sh−600$10,800→ 183,216 total
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2023.